Format

Send to:

Choose Destination
See comment in PubMed Commons below
Skin Therapy Lett. 2008 Feb;13(1):1-5.

Psoriasis as the marker of underlying systemic disease.

Author information

  • 1The University of Texas Southwestern Medical School, Dallas, TX, USA.

Abstract

Psoriasis is associated with comorbidities that include metabolic syndrome and increased cardiovascular risk. These conditions share etiologic features and health consequences that directly correlate with the severity of psoriatic disease. This disease, in both its skin and joint manifestations, may represent a relevant healthcare issue as an indicator of a broader, underlying disorder of systemic inflammation, and warrants more comprehensive study and multidisciplinary collaboration on its pathophysiology, epidemiology, and treatment in relation to its comorbid conditions.

PMID:
18357363
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Skin Therapy Letter
    Loading ...
    Write to the Help Desk